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Abstract
Background and importance The suprasellar and hypo-
thalamic/chiasmatic regions can harbor a broad range of
pathologic conditions, both neoplastic and nonneoplastic;
however, malignant gliomas are extremely rare in those
regions.
Clinical presentations Patient 1 was a 70 year-old man
with weight loss and rapidly progressive visual impair-
ment. A mass centered in the hypothalamus was detected
on magnetic resonance (MR) imaging. The second patient,
a 45 year-old woman, complained of visual symptoms and
headaches. MR imaging revealed a combined intra- and
suprasellar mass. In both instances, the preoperative dif-
ferential diagnosis favored craniopharyngioma. Histologi-
cal examination confirmed the diagnosis of glioblastoma.
Conclusion We report two rare adult cases of hypotha-
lamic/chiasmatic glioblastoma. The authors review the
literature, highlighting the importance of considering this
rare entity in the differential diagnosis of suprasellar and
hypothalamic lesions.
Keywords Chiasm  Glioblastoma  Hypothalamus 
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Introduction
Glioblastoma (GBM) constitutes the most common adult
brain tumor, with most cases arising in the subcortical
white matter of the cerebral hemispheres. Examples of
GBM in the hypothalamic/chiasmatic or suprasellar region
have been seldom reported. We report two rare cases of
suprasellar or hypothalamic/chiasmatic region GBM that
were radiographically interpreted as being consistent with
craniopharyngioma. Our report emphasizes the challenges
of preoperative diagnosis and the important role of patho-
logic examination in establishing the diagnosis.
Case reports
Clinical presentation case 1
This 70 year-old man reported a 3-month history of appetite
loss with accompanying weight loss and rapidly progressive
visual loss and fatigue for 4 weeks. In addition, gait diffi-
culties and left hemiparesis emerged 4 days prior to
admission to the hospital. Endocrinologically, there was a
hypopituitarism identified with low blood level of thyroid-
stimulating hormone (0.03 mU/l, reference 0.30–3.18 mU/
l), normal level of adrenocorticotropic hormone (ACTH)
and higher level of prolactin (29.2 lg/l, reference
4.0–15.2 lg/l). Blood levels were also decreased for tes-
tosterone (\0.09 nmol/l, reference 4.59–31.1 nmol/l) and
cortisol (13 mmol/l, reference 171–536 mmol/l). Past
medical history was significant for hypertensive cardio-
myopathy; normochromic, normocytic anemia; and pul-
monary emphysema. There was no known history of
inherited tumor syndromes. The patient reported a 17-pack-
year smoking history 29 years prior to admission.
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Medications included prednisone 5 mg, vitamin D3, and
calcium. As part of the workup, he underwent magnetic
resonance (MR) imaging. A contrast-enhancing mass lesion
centered on the hypothalamus measuring 2.3 9 2.8 9
2.1 cm was identified (Fig. 1a, b). Anteriorly, the lamina
terminalis appeared distorted. The findings were reported to
be most consistent with craniopharyngioma, with less likely
considerations including germinoma, glioma, metastasis,
lymphoma, or sarcoidosis.
Operation and postoperative course
As the tumor involved nearly the complete hypothalamus,
the aim of surgery was biopsy or partial resection by
transsphenoidal approach rather than total tumor removal.
Intraoperatively, the tumor was identified above the pitui-
tary gland, appeared greyish yellow, and was soft and
amenable to partial removal by suctioning. Intraoperative
histopathologic consultation revealed the diagnosis of a
malignant glioma. The patient recovered well from the
operation; however, 1 month after discharge, he was seen
in another hospital after experiencing what was described
as a collapse. Further details of the episode are not avail-
able; however, records indicate that he rejected radiation
and adjuvant chemotherapy, because the family elected to
pursue alternative medicine options.
Histological examination
Pathological evaluation revealed a moderately cellular
neoplasm comprising cells with irregular-shaped nuclei
and eosinophilic cytoplasm and fibrillary processes
(Fig. 2a). Scattered mitotic figures and pathologic vessel
proliferation were seen, but necrosis was not identified.
Rosenthal fibers or eosinophilic granular bodies were not
seen. Immunohistochemical stains performed on formalin-
fixed, paraffin-embedded tissue revealed a MIB1
proliferation index of up to 30%. The neoplastic cells
showed strong, diffuse immunoreactivity for glial fibrillary
acidic protein (GFAP) (Fig. 2b). In addition, approxi-
mately 70% of the tumor cells showed nuclear positivity
for p53, whereas, IDH1 staining (p.R132H) was negative.
On the basis of the morphologic and immunohistochemical
features, a diagnosis of glioblastoma was made. Analysis of
the MGMT promoter revealed no methylation in the tumor
cells.
Clinical presentation case 2
This 45-year-old woman presented with 3-year history of
bitemporal visual field defects, which progressed over
recent months. More specifically, approximately 3–4
weeks prior to admission, she noted a slowly progressive
narrowing of the left temporal visual field combined with
impaired vision and fluctuating visual loss lasting a few
seconds, accompanied by partial diplopia. In addition, she
complained of headache, diminished appetite, amenorrhea,
and lack of energy. Symptoms of diabetes insipidus, pitu-
itary insufficiency, or weight loss were not reported. The
patient reported no known family history of tumors.
Examination showed anisocoria left [ right and suspi-
cion for hypogonadotropic hypogonadism with low levels
of luteinizing hormone (0.3 U/l), follicle-stimulating hor-
mone (4.0 U/l) and estradiol (40 pmol/l). There were no
further neurological deficits or signs of increased intra-
cranial pressure. MR studies showed an intra- and supra-
sellar, predominantly solid, partially multicystic tumor
(21 9 24 9 36 mm) (Fig. 1c, d), with ventral displace-
ment and compression of the optic chiasm and lateral
displacement of both optic nerves. The tumor extended
from the upper diaphragma sellae to the tuberculum sellae,
with a small component lateral to the left planum sphe-
noidale. The cystic components of the tumor appeared to
extend into the third ventricle. The dorsal tumor border
Fig. 1 T1-weighted magnetic resonance images after gadolinium injection. a, b Irregular, contrast-enhancing mass centered on the
hypothalamus that extends into the sella (patient 1). c, d Suprasellar, partially cystic mass with leptomeningeal enhancement (patient 2)
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extended into the interpeduncular and prepontine cisterns
with spread in the crus cerebri and ventrally in the pons.
The imaging features were interpreted as compatible with
craniopharyngioma, or less likely, germinoma or glioma.
Operation and postoperative course
The patient initially underwent a transsphenoidal partial
tumor resection. Intraoperatively, the tumor appeared to be
clearly separated from the tissue of the pituitary gland and
partly surrounded by a greyish capsule. The tumor itself
was of a light greyish yellow color with a soft consistency.
However, some portions, especially toward the right lateral
tumor margin, appeared firm and adherent to neighboring
structures. As the intraoperative diagnosis was that of a
malignant glioma, the firm tumor parts were not totally
removed. Good adequate hemostasis could be achieved
toward the end of the operation. Postoperatively, the
patient awakened more slowly than expected and with
anisocoria and right-sided hemiparesis. Emergency com-
puted tomography (CT) scan showed blood in the tumor
resection bed, so the patient underwent a pterional crani-
otomy for evacuation of the hematoma. Because of com-
plications of postoperative hemorrhage after the second
surgery, the patient died on the second postoperative day.
No postmortem examination was performed.
Histological examination
Similar to the first case, histological examination of the
biopsy revealed an infiltrating glial neoplasm composed of
densely packed tumor cells with an astrocytic phenotype.
The GFAP-positive neoplastic cells were moderately
pleomorphic and mitotically active. Prominent microvas-
cular proliferation and necrosis were present (Fig. 2c, d).
The MIB1 proliferation index was markedly increased,
with up to 15% positive nuclei. The tumor cells showed
10% immunoreactivity for p53 and negativity for IDH1
(p.R132H). Analysis of the MGMT promoter revealed no
methylation in the tumor tissue.
Discussion
This report describes two well-documented examples of
primary GBM arising in the suprasellar or hypothalamic/
chiasmatic region. Although malignant gliomas may
involve this region secondarily, tumors arising in this
region are exceedingly uncommon. On the basis of the
complex anatomy of the region with many different tissue
types, the differential diagnosis of nonglial suprasellar
lesions is extensive and encompasses both neoplastic and
nonneoplastic lesions. Primary neoplasms include cranio-
pharyngiomas, pituitary adenomas, germ-cell tumors,
meningiomas, and pituicytomas, among others [7]. In
addition, Langerhans cell histiocytosis [9] and hypotha-
lamic hamartomas are recognized in this region [14, 18].
Major secondary tumors comprise metastatic carcinoma
[7], melanoma [21], leukemias [10], and lymphomas [7].
Langerhans cell histiocytosis can also spread to the
suprasellar region from a primary systemic site [8]. A
comprehensive search of the PubMed/MEDLINE database
yielded only five publications of glioblastoma centered on
this region [2, 4, 6, 11, 22].
In 1973, Hoyt [11] published the first discussion of
malignant gliomas of the optic nerve and established the
concept of a rapidly progressive syndrome of visual loss in
middle-aged men, which was often mistaken for ischemic
optic neuropathy. Given the different and variably applied
grading for malignant gliomas at that time, the precise
pathologic diagnosis of the cases reported remains uncer-
tain. Subsequently, Barbaro et al. [2] presented the case of
a 26-year-old man with headaches and rapidly progressive
visual loss that on CT scans was felt to be consistent with
craniopharyngioma or cystic pituitary adenoma. Pathologic
examination of the biopsy revealed a glioblastoma.
Another example was reported in the optic tract of a
76-year-old man who complained of progressive deterio-
ration of vision in his left eye over a 6-month period [22].
CT showed a suprasellar contrast-enhancing mass invading
the left temporal lobe. On T1-weighted MR imaging of the
head, there was inhomogeneous gadolinium enhancement
with cystic areas of the expanded left optic nerve, chiasm,
Fig. 2 Histologic features: a, c hematoxylin and eosin; b, d and glial
fibrillary acidic protein (GFAP). a, b Patient 1; c, d patient 2. a,
c Astrocytic tumors with microvascular proliferation typical of
glioblastoma. b, d Tumor cells show positive immunoreactivity for
GFAP. a–d Original magnification 920
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and left optic tract. Expansion of the optic nerve dimin-
ished rapidly anterior to the chiasm and the intraorbital
portion was of normal thickness, without enhancement
[22]. In reference to this case, Pallini [19] wrote a letter to
the editor that detailed a personal case of a 59-year-old
woman with an optic chiasm glioblastoma. On imaging, the
tumor appeared to diffusely infiltrate the hypothalamus and
basal ganglia but spared the intraorbital portion of the optic
nerves, similar to the cases presented in this report.
Wu-Chen et al. [23] reported that a 63-year-old man
developed a malignant astrocytoma of the left optic nerve
and chiasm 23 years after partial excision and radiation of
a nonsecreting pituitary adenoma. In another case report,
the authors described a 5-year-old boy who presented with
profound bilateral visual loss and was diagnosed with an
optic nerve tumor that transformed from a low-grade
astrocytoma, with features most consistent with a pilocytic
astrocytoma (PA), to a malignant glioma without any
exposure to radiation therapy [24]. Similarly, Cirak [4]
reported a 6-year-old girl who presented with visual dete-
rioration that had progressively worsened over 2 months.
MR imaging revealed a sellar, para- and suprasellar lesion,
and intraoperatively, the tumor appeared to arise from the
optic chiasm. In the cases presented here, optic pathway
origin is unlikely because of the displacement and lack of
evidence of direct involvement of those structures.
Gliomas in this location are typically low grade, such as
PA of the optic nerve, which are seen mostly in the pedi-
atric population and may be associated with neurofibro-
matosis (NF)1 [1]. Of interest, NF1-associated PA of the
optic pathway tends to have a more benign course, and
radiation therapy is generally avoided. Radiographically,
PAs show variable features but are usually well-demar-
cated lesions. On MR, they can appear hypodense or iso-
dense, and a few are hyperdense, with the majority
showing moderate to marked enhancement [15]. On
occasion, PA in this region may extend into the sellar
region, and when large, they may even erode the sphenoid
bone. They are rarely calcified, are usually isointense on
T1, and usually lack a cystic component [5].
Pilomyxoid astrocytoma (PMA) is an uncommon, more
aggressive, variant of pilocytic astrocytomas that exhibits a
predilection for the diencephalic region in infants and
young children (mean age 1.5 years), although it was
recently reported that up to one third of patients are older
children and adults [16]. Similar to PA, PMA remains a
histologic diagnosis without definitive imaging findings
[12]. Gross total resection is the treatment of choice, but
surgery is often limited due to high morbidity and mortality
rates. Patient age, rapidly progressive time course, and
high-grade histopathologic features in the cases reported
herein argued against consideration of either of PA or its
pilomyxoid variant.
Another rare tumor that shows a predilection for the
third ventricle and suprasellar region is the chordoid gli-
oma, with approximately 50 cases reported in the literature.
This entity displays distinct histological features and is
hypothesized to originate along the third ventricle floor
and/or the lamina terminalis [20]. The typical mucinous
background and cord-like arrangement of the neoplastic
cells was not observed in either of our cases. Furthermore,
malignant progression has not been seen in chordoid gli-
oma. Despite their low-grade histology, location of these
tumors often precludes complete resection and recurrence,
and poor outcome is inevitable [20].
Spindle-cell oncocytoma is another extremely rare and
often misdiagnosed tumor of uncertain histogenesis that
occurs in the sellar region [3, 17]. Radiographically, it can
mimic the appearance of craniopharyngioma, and recur-
rences are recognized [13]. Although the histopathologic
features may resemble an astrocytic tumor, the distinctive
immunohistochemical profile and ultrastructure militated
against this consideration in our patients.
The rarity of malignant gliomas in this location and their
heterogeneous presentation on imaging renders this a dif-
ficult diagnosis prior to obtaining tissue for histological
analysis. On T1-weighted images, most lesions considered
in the differential diagnosis appear iso- or hypointense. The
presence of protein, cholesterol, or methemoglobin may
cause a high signal, which would be more likely encoun-
tered in craniopharyngioma. However, enhancement after
gadolinium is seen in both craniopharyngioma and high-
grade gliomas. Postoperative imaging is also crucial to
monitor potential complications and recurrence.
Due to the presence of central necrosis, a rare abscess is
also included in the differential diagnosis. Correlation with
clinical status (infectious signs with fever in abscess) and
diffusion-weighted images (diffusion restriction in abscess)
help in the differential diagnosis between these two rare
entities.
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